Moomoo AI 已提取核心訊息
Aditya P. Mohanty, the Chief Executive Officer of Biora Therapeutics, Inc. (BIOR), was granted 819,000 shares of common stock on February 15, 2024. The transaction, which is currently in progress, was conducted at no cost to the executive. Following this grant, Mohanty's direct holdings in the company increased to a total of 1,539,492 shares of common stock. The nature of the shares acquired is direct, reflecting Mohanty's vested interest in the company's performance.
Aditya P. Mohanty, the Chief Executive Officer of Biora Therapeutics, Inc. (BIOR), was granted 819,000 shares of common stock on February 15, 2024. The transaction, which is currently in progress, was conducted at no cost to the executive. Following this grant, Mohanty's direct holdings in the company increased to a total of 1,539,492 shares of common stock. The nature of the shares acquired is direct, reflecting Mohanty's vested interest in the company's performance.
2024年2月15日，Biora Therapeutics, Inc.（BIOR）首席執行官阿迪亞·莫漢蒂獲得了81.9萬股普通股。該交易目前正在進行中，是高管免費進行的。在這筆贈款之後，莫漢蒂在該公司的直接持股量增加到總共1,539,492股普通股。收購的股票的性質是直接的，反映了莫漢蒂在公司業績中的既得利益。
2024年2月15日，Biora Therapeutics, Inc.（BIOR）首席執行官阿迪亞·莫漢蒂獲得了81.9萬股普通股。該交易目前正在進行中，是高管免費進行的。在這筆贈款之後，莫漢蒂在該公司的直接持股量增加到總共1,539,492股普通股。收購的股票的性質是直接的，反映了莫漢蒂在公司業績中的既得利益。
有用
沒用